ZAGREB, Feb 26 (Reuters) - Slovenian generic drugs producer
Krka KRKG.LJ KRK.WA said on Thursday it achieved a group net
profit of 166.2 million euros in 2014 versus 172.7 million in
2013.
Sales fell to 1.19 billion euros from 1.20 billion, but Krka
said it saw sales rising this year.
"Krka's sales in 2015 are planned to amount to 1.26 billion
euros, with sales outside Slovenia expected to represent 94
percent of total sales. Profit is planned at the level of the
profit reported for 2014," the company said in a report filed to
the Ljubljana bourse.
(Reporting by Igor Ilic; Editing by David Holmes)
((Marja.Novak@thomsonreuters.com; Reuters Messaging:
marja.novak.thomsonreuters.com@reuters.net))
Keywords: KRKA RESULTS/